APA

Märten A., Schmidt J., Ose J., Harig S., Abel U., Münter M. W., Jäger D., Friess H., Mayerle J., Adler G., Seufferlein T., Gress T., Schmid R. & Büchler M. W. (20090727). A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2. : BMC cancer.

Chicago

Märten Angela, Schmidt Jan, Ose Jennifer, Harig Sabine, Abel Ulrich, Münter Marc W, Jäger Dirk, Friess Helmut, Mayerle Julia, Adler Guido, Seufferlein Thomas, Gress Thomas, Schmid Roland and Büchler Markus W. 20090727. A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2. : BMC cancer.

Harvard

Märten A., Schmidt J., Ose J., Harig S., Abel U., Münter M. W., Jäger D., Friess H., Mayerle J., Adler G., Seufferlein T., Gress T., Schmid R. and Büchler M. W. (20090727). A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2. : BMC cancer.

MLA

Märten Angela, Schmidt Jan, Ose Jennifer, Harig Sabine, Abel Ulrich, Münter Marc W, Jäger Dirk, Friess Helmut, Mayerle Julia, Adler Guido, Seufferlein Thomas, Gress Thomas, Schmid Roland and Büchler Markus W. A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2. : BMC cancer. 20090727.